​

Funding Round

Series C - Cambrooke Therapeutics

Series C - Cambrooke Therapeutics

Investment Firm

Overview

Cambrooke Therapeutics recognizes the critical nature of managing serious medical disorders through medically based nutrition therapies.

Announced Date

Apr 11, 2016

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Seventure Partners

Seventure Partners

Seventure Partners is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed firm.

Participant Investors

3

Investor Name
Participant InvestorRuffena Capital
Participant InvestorGalen Partners
Participant InvestorSeventure Partners

Round Details and Background

Cambrooke Therapeutics raised an undisclosed amount on 2016-04-11 in Series C

Cambrooke Therapeutics recognizes the critical nature of managing serious medical disorders through medically based nutrition therapies.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 11, 2010
Venture Round - Cambrooke Therapeutics
-250.0K
Apr 11, 2016
Series C - Cambrooke Therapeutics
3-undefined
Feb 17, 2011
Venture Round - Cambrooke Therapeutics
-10.0M

Recent Activity

There is no recent news or activity for this profile.